Tirzepatide is the first agonist to interact with a second receptor, called glucose-dependent insulinotropic polypeptide, or GIP, which affects insulin levels and blood sugar similarly to GLP-1
However, so far across studies with GLP1R agonists , cardiovascular measurements such as blood pressure have seen improvements in general, with no significant increases in adverse cardiovascular effects seen in patients even after 2 years (In fact, decreases were seen), suggesting that the cardiovascular benefits of decreased body weight may overcome any potential harm that increases in heart rate by GLP1R agonists may cause
The unique ability of MRGPRX2 to respond to a broad range of ligands highlights its importance in host defense mechanisms and its potential as a therapeutic target for treating allergic and inflammatory diseases
Tessema M, Gunaratna NS, Brouwer ID, Donato K, Cohen JL, McConnell M, Belachew T, Belayneh D, De Groote H
A decline in estrogen levels during menopause (usually occurring in the late 40s or 50s) can contribute to the acceleration of muscle loss in women